Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The EXOPRO Study: How Does Prostate Cancer Metastasize? Understanding the Role of Exosomal Communication in Lean vs Obese Patients

NCT04167722 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04167722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04167722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The EXOPRO Study: How Does Prostate Cancer Metastasize? Understanding the Role of Exosomal Communication in Lean vs Obese Patients
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2019
Completion date
October 1, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, prostate cancer